Safety and efficacy of second-line treatment with folinic acid, 5-fluorouracil and irinotecan (FOLFIRI) in combination of panitumumab and bevacizumab for patients with metastatic colorectal cancer
Crossref DOI link: https://doi.org/10.1007/s12032-014-0035-3
Published Online: 2014-06-12
Published Print: 2014-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xie, Song
Han, Guoping
Fan, Zhikun
He, Lifeng
Xu, Wenbing
Qin, Zhen
Text and Data Mining valid from 2014-06-12